Scholar Rock wins FDA approval for first drug to target SMA muscle loss
Scholar Rock wins FDA approval for first drug to target SMA muscle loss STAT
Regulatory Approvals
US FDA approves Scholar Rock’s muscle weakness drug
US FDA approves Scholar Rock's muscle weakness drug Reuters
FDA clears Pharming’s Joenja for young children with immune disorder
FDA clears Pharming's Joenja for young children with immune disorder FirstWord Pharma
FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications
FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications Oncology Nursing News
FDA Approval of Daraxonrasib in Pancreatic Cancer
FDA Approval of Daraxonrasib in Pancreatic Cancer OncLive